ERBC (European Research Biology Center)
Diana Badr is an experienced Human Resources Business Partner and Head of Global Talent Acquisition & Talent Management at the European Research Biology Center since June 2023. Prior to this, Diana served as a Senior Talent Acquisition Manager at Robert Walters from October 2018 to June 2023, where responsibilities included team management, cross-functional project leadership, and full-cycle recruitment across diverse industries, achieving top performance in 2021. Previous experience includes roles at Sterela in business development and strategic marketing, as well as project management internships at the CNRS focused on molecular biology, microbiology, and anthropobiology. Diana holds an Advanced Master in Technological Innovation Management from TBS Education and multiple degrees in biology, health, ecology, and life sciences from Université Paul Sabatier Toulouse III.
This person is not in any offices
ERBC (European Research Biology Center)
Stemming from the merger of two reference CROs in pharmacology and toxicology (CERB and RTC), European Research Biology Center (ERBC) is a European leader in non-clinical studies. It offers to healthcare and chemical professionals a comprehensive range of experimental capabilities, preclinical models, regulatory pre-IND package and consultancy services to de-risk innovation and improve R&D productivity. Based in Baugy (France) and Roma (Italy), ERBC provides all services from preclinical proof-of-concept to market of any type of drug candidate or chemical compound. Each project is managed by a study director, relying on a multi-disciplinary team of experts, notably in general pharmacology, cardiology, electrophysiology and pathophysiology, also benefiting from a world class academic and private network. Every year, study reports from our two Centers are successfully used in support of market authorization and new product approval submissions around the world, including the European (EMA, ECHA), US (FDA and EPA) and Japanese (MHLW and MAFF) regulatory authorities. Investment in outstanding scientific and technical manpower, high-tech equipment and facilities are crucial cornerstones of our sound and organic growth. The quality and reliability of our performance is reflected by the many ongoing and long-lasting collaborations we maintain with leading international pharmaceutical and chemical companies. ERBC is deeply engaged in animal ethics and welfare. ERBC supports the Basel Declaration, respects the 3Rs concept and continually improves its tools and procedures to maximize the balance between the benefit for health and the animal well-being.